Home > Compound List > Product Information
Debrisoquin_Molecular_structure_CAS_1131-64-2)
Click picture or here to close

Debrisoquin

Catalog No. DB04840 Name DrugBank
CAS Number 1131-64-2 Website http://www.ualberta.ca/
M. F. C10H13N3 Telephone (780) 492-3111
M. W. 175.23032 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 4384

SYNONYMS

IUPAC name
1,2,3,4-tetrahydroisoquinoline-2-carboximidamide
IUPAC Traditional name
debrisoquin
Brand Name
Declinax
Equitonil
Tendor
Synonyms
Debrisoquin sulfate
Debrisoquin hemisulfate
Debrisoquine
Debrisoquina [inn-spanish]
Debrisochinum
Debrisoquine sulfate
Debrisoquinum [inn-latin]
Isocaramidine
Isocaramidine sulfate

DATABASE IDS

CAS Number 1131-64-2
PubChem CID 2966
PubChem SID 46507664

PROPERTIES

Hydrophobicity(logP) 0.75 [SANGSTER (1994)]

DETAILS

Description (English)
Item Information
Drug Groups approved
Description An adrenergic neuron-blocking drug similar in effects to guanethidine. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism. [PubChem]
Indication For the treatment of moderate and severe hypertension, either alone or as an adjunct, and for the treatment of renal hypertension.
Pharmacology Debrisoquin is an adrenergic neuron-blocking drug similar in effects to guanethidine. It is a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.
Affected Organisms
Humans and other mammals
Biotransformation Hepatic.

REFERENCES